Parliamentary Report Recommends Ban On Controversial Anti-Malarial Drug Lariam For British Soldiers

The recent parliamentary report has sparked significant discussions regarding the safety of anti-malarial medications prescribed to British soldiers. This report highlights the potential dangers associated with Lariam, a drug that has been linked to severe mental health issues in service members. As the Ministry of Defence faces mounting pressure, campaigners are advocating for a comprehensive ban on the use of this controversial medication.

The findings of the Defence Select Committee, released recently, indicate that Lariam may only be prescribed in highly restricted circumstances. This decision is seen as a pivotal moment for many former military personnel who have experienced distressing side effects from the drug. The report's recommendations could pave the way for numerous legal cases against the Ministry of Defence, reflecting the urgency of the situation.

General Lord Richards, the former head of the British military, has expressed the need for immediate action. He believes that the recognition of Lariam's dangerous side effects is long overdue and emphasizes the importance of implementing the report's recommendations without delay. His insights underline the ongoing concerns about the drug's impact on soldiers and their well-being.

• Campaigners hope for a complete ban on Lariam.
• Hundreds of legal cases are pending against the Ministry of Defence.
• General Lord Richards calls for urgent action on the report's recommendations.
• Recognition of Lariam's dangers is considered long overdue.

Lady Caroline Richards, the general's wife, has also been vocal about the experiences of those affected by Lariam. She highlights the emotional toll the drug has taken on relationships and mental health, reinforcing the need for a thorough investigation into its use. This sentiment resonates with many families who have witnessed the adverse effects on their loved ones.

Lariam, known generically as Mefloquine, was developed by the US Army in the 1970s and has faced scrutiny for its side effects. Notably, the US Food and Drug Administration has issued warnings regarding potential neuropsychiatric effects that may persist even after stopping the medication. The ongoing debate about its safety continues to raise questions about the responsibility of military authorities in safeguarding the health of their personnel.

As the British military reevaluates its use of Lariam, the hope remains that this report will lead to significant changes in drug prescribing practices. The well-being of soldiers must take precedence over outdated protocols, ensuring that those who serve their country receive the care and consideration they deserve.

Key Takeaways